王拥军:中国卒中报告2019发布

2020-09-24 王拥军 Stroke & Vascular Neurology 发表于威斯康星

Stroke & Vascular Neurology

Stroke & Vascular Neurology(SVN)最新上线文章“China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations”,由首都医科大学附属北京天坛医院赵继宗院士、王拥军教授牵头,联合国家神经系统疾病医疗质量控制中心、国家神经系统疾病临床医学研究中心、中国卒中学会、中国疾病预防控制中心慢性非传染性疾病预防控制中心、全球神经科学及卒中协同会等共同参与完成。

为什么要发布《中国卒中报告 2019》?

 

近年来,卒中已成为导致我国居民死亡的主要原因之一。据全球疾病负担工作组估算卒中终生风险:全球为24.9%,中国为39.3%,中国已成为卒中终生风险最高和疾病负担最重的国家。为进一步让全世界更为直观地了解中国卒中现状,国家神经系统疾病医疗质量控制中心在国家卫生健康委员会医政医管局的指导下,联合国家神经系统疾病临床医学研究中心、中国卒中学会、中国疾病预防控制中心慢性非传染性疾病预防控制中心及全球神经科学及卒中协同会等机构共同撰写了《中国卒中报告 2019》,英文版一文发布在SVN杂志上。

该报告旨在描述我国城乡居民卒中流行病学现况和危险因素,卒中患者的发病状况、临床特征、诊疗流程及院内结局等疾病发生和医疗质量等指标,将为相关机构更好地预防疾病发生、快速高效诊疗、提升医疗质量、优化资源分配及制定相关卫生和研究政策等提供科学的数据信息支持。

本次报告所使用的数据来源于十余个行业及国家级数据库,其中涉及卒中疾病监测、流行病学调查、国家卒中登记等注册研究(见下表),以及国家卫生健康委国家医院质量监测系统(HQMS)等行政管理数据库,能够较为全面地反映中国卒中的预防和诊疗现况。该报告是我国近年来第一份较为全面地反映中国卒中流行现状、住院期间医疗质量诊疗水平和院内结局的英文版统计报告,以期为全球卒中的预防和诊疗提供中国经验。

 

《中国卒中报告 2019》的主要内容

卒中流行病学数据

1. 在我国每5位死亡者中至少有1人死于卒中

 2018年,中国居民脑血管病死亡率为149.49/10万,占我国居民总死亡率的22%。其死亡率呈现男性高于女性、农村高于城市的特点。同时,农村居民的卒中发病率和患病率也显著高于城市居民。卒中已成为造成过早死亡和疾病负担的首位原因。

2. 2005-2018年,中国居民脑血管病粗死亡率总体呈缓慢上升趋势。

脑血管病粗死亡率呈上升趋势的主要原因是人口老龄化。多年来,农村地区脑血管病粗死亡率均高于城市。此外,农村地区脑血管病的发病率和患病率也明显高于城市。

卒中的危险因素

高血压和吸烟是卒中预防和管理中的首要危险因素。

在卒中幸存患者中最普遍的危险因素是高血压(63.0%-84.2%)和吸烟(31.7%-47.6%),其次是血脂异常和糖尿病,心房颤动比例相对较低(2.7%-7.4%)。上述危险因素在全人群中也呈现较高的流行水平。根据国家相关疾病的流行病学调查数据,目前我国15岁及以上人群现在吸烟率为26.6%,18岁及以上人群高血压患病率为25.2%。这些均提示高血压仍是卒中防治的重中之重。

卒中住院患者情况

HQMS2018年纳入卒中住院病人301万,缺血性卒中约占82%,年龄为66岁,出血性卒中患者更年轻;女性约占40%,尤其在蛛网膜下腔出血患者中,女性占比更高。 

超过一半的出血性卒中患者是通过急诊入院的;缺血性卒中患者工作日入院较多,且周一入院者更多。这提示我国目前脑血管疾病急救系统使用不足,缺血性卒中患者在院前不正确地转运与延误等方面仍存在很大问题。

卒中住院患者医疗保险覆盖情况  

在卒中住院患者医保类型中,城镇居民、城镇职工、新农合三者累计覆盖超过75%(城镇居民医保覆盖35.3%,城镇职工医保覆盖23.2%,新型农村合作医疗覆盖16.3%),自付比例约10%(其中包括部分异地就诊的患者);出血性卒中患者自付比例较高。

卒中亚型与地域

基于医疗质量管理系统的数据分析显示,在高海拔地区卒中患者中,出血性卒中的比例更高,如西藏自治区出血性卒中所占比例为61%,青海省为44%,贵州省为35%。

卒中住院患者的年龄分布

这次报告首次分析报告了儿童卒中,儿童卒中(<18岁)的脑梗死、脑出血和蛛网膜下腔出血三种类型占比分别为0.1%、0.6%和1.4%。卒中住院患者年龄集中在50岁及以上;65岁前,男性比例高;65岁后,女性比例较高。

卒中住院患者的危险因素

高血压是卒中患者首要的危险因素,肺炎/肺部感染是首要的并发症。其中,脑梗死患者合并肺炎/肺部感染的比例为10.1%,脑出血患者为31.4%,蛛网膜下腔出血患者为25.2%。

卒中住院患者院内结局  

卒中住院患者院内死亡/非医嘱离院的比例为8.3%,其中脑梗死患者院内死亡/非医嘱离院的比例为5.8%、脑出血患者为19.5%、蛛网膜下腔出血患者为19.4%;住院时间的中位数为 10天,其中脑梗死患者为10天、脑出血患者为14天、蛛网膜下腔出血患者为12天。

卒中住院患者遵循指南的干预指标

脑梗死、脑出血、蛛网膜下腔出血住院患者遵循指南治疗的指标综合执行率分别为0.77±0.21、0.72±0.28和0.59±0.32。其中,3.5小时到院且无溶栓禁忌症的缺血性卒中患者,接受重组组织型纤溶酶原激活剂静脉溶栓治疗的比例为24%;缺血性卒中合并房颤患者出院时使用抗凝药物的比例为43.8%;所有收治入院的缺血性卒中患者中行动脉内机械取栓术的比例为28.1%。

最后王院长还分享了关于中国脑血管病医疗质量的改进技术体系——“金桥”体系的一些研究,并总结了脑血管病防治的关键点:(1)参考临床研究,提供更多证据;(2)遵循循证指南,改善医疗质量。

原始出处:

Yong-Jun Wang, Zi-Xiao Li, Hong-Qiu Gu, Yi Zhai, Yong Jiang, Xing-Quan Zhao, Yi-Long Wang, Xin Yang, Chun-Juan Wang, Xia Meng, Hao Li, Li-Ping Liu, Jing Jing, Jing Wu, An-Ding Xu, Qiang Dong, David Wang, Ji-Zong Zhao  On behalf of China Stroke Statistics 2019 Writing Committee .China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. doi: 10.1136/svn-2020-000457

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-11-30 Tom

    这个平台很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 Alimin

    卒中是人类的一大杀手

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 Psycho.Dr Du

    中风#卒中#现在正在越来越年轻化

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 ms1000000777470087

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=903717, encodeId=a959903e1777, content=这个平台很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/92294907c46e4a52b8f470ac900f1664/46dd8aca0be34716b483eb2c1b4487f2.jpg, createdBy=18345171209, createdName=Tom, createdTime=Mon Nov 30 23:42:07 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888123, encodeId=27fd888123b0, content=卒中是人类的一大杀手, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200924/3b18abf3a3054617ac960c3c5316e499/9c90c151248e483a9e9fb8b121640b58.jpg, createdBy=4c715267550, createdName=Alimin, createdTime=Thu Sep 24 23:38:08 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026694, encodeId=f3ff1026694b3, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Sep 24 15:13:29 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887973, encodeId=b1bd88e973e9, content=中风<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>现在正在越来越年轻化, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210607/9f00a0de660e4b36b77a9a5f7620d6bf/98c22b17ddf7446fa7b9a618fabcb9f7.jpg, createdBy=a8fb2299762, createdName=Psycho.Dr Du, createdTime=Thu Sep 24 15:13:19 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887964, encodeId=05ca88e96497, content=。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c85421236, createdName=ms1000000777470087, createdTime=Thu Sep 24 14:58:49 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887913, encodeId=558388e913cd, content=<a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a>报告也可以发表, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35999, encryptionId=b64035999ca, topicName=卒中)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Sep 24 13:22:11 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 lovetcm

    #卒中#报告也可以发表

    0

相关资讯

Stroke:西洛他唑用于卒中和认知功能下降的二级预防

西洛他唑可以有效长期预防复发性卒中,而不会增加出血的风险。但是,大多数与亚太地区患者有关的试验以及西方国家的更多试验应评估其对认知功能下降、功能结局和耐受性的影响。

Neurology:COVID-19患者的卒中风险、临床表型和死亡情况分析

COVID-19患者发生卒中相对频繁,并且各个年龄段患者都有严重的结局。老年人、合并症和COVID-19呼吸系统症状严重程度之间的相互作用与患者极高的死亡率相关。

Stroke:胰岛素样肽-1受体激动剂可降低T2D患者非致命性卒中的发病风险

本研究旨在对CVOTs(心血管结果试验)进行荟萃分析,以评估糖皮质激素样肽-1受体激动剂治疗对降低2型糖尿病患者卒中风险的效果。

J Cereb Blood Flow Metab:卒中诱导的免疫抑制和吞咽困难与卒中相关肺炎独立相关

脑卒中相关肺炎是脑卒中后常见的并发症,与不良结局有关。吞咽困难是脑卒中相关肺炎的已知危险因素,但现有的证据表明,脑卒中诱导的免疫抑制状态增加了脑卒中相关肺炎的易感性。本研究旨在通过研究单细胞HLA-D

类似于急性冠脉综合征及中风,你会想起该病吗?

嗜酸性肉芽肿性多血管炎,也称为Churg-Strauss综合征(churg-strauss syndrome,CSS),以哮喘、嗜酸性粒细胞增多及血管炎为临床表现的、累及多器官的罕见疾病。

Neurology:服用达比加群卒中患者的溶栓治疗

达比加群酯(达比加群)是一种直接凝血酶抑制剂,已被证明可预防心房颤动患者的卒中。伊达鲁珠单抗(Idarucizumab)是一种人源化单克隆抗体片段,旨在逆转达比加群的抗凝作用。伊达鲁珠单抗与达比加群的